These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15855356

  • 21. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L, Di Cesare Mannelli L, Guerrini R, Trapella C, Zanardelli M, Ciccocioppo R, Rizzi A, Ghelardini C, Calò G.
    Eur J Pharmacol; 2015 May 05; 754():73-81. PubMed ID: 25704616
    [Abstract] [Full Text] [Related]

  • 22. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E, Babos F, Fischetti C, Magyar A, Camarda V, Borsodi A, Bajusz S, Calo' G, Benyhe S.
    Brain Res Bull; 2010 Mar 16; 81(4-5):477-83. PubMed ID: 19800951
    [Abstract] [Full Text] [Related]

  • 23. Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats.
    Kapusta DR, Dayan LA, Kenigs VA.
    Clin Exp Pharmacol Physiol; 2002 Mar 16; 29(3):254-9. PubMed ID: 11906494
    [Abstract] [Full Text] [Related]

  • 24. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S, Camarda V, Rizzi A, Marzola G, Salvadori S, Marzola E, Molinari P, McDonald J, Ko MC, Lambert DG, Calo' G, Guerrini R.
    Br J Pharmacol; 2013 Jan 16; 168(1):151-62. PubMed ID: 22827708
    [Abstract] [Full Text] [Related]

  • 25. Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs.
    Hashiba E, Hirota K, Kudo T, Calo' G, Guerrini R, Matsuki A.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr 16; 367(4):342-7. PubMed ID: 12690425
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 16; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 29. ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries.
    Simonsen U, Laursen BE, Petersen JS.
    Br J Pharmacol; 2008 Mar 16; 153(6):1185-94. PubMed ID: 18193068
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H, Calo' G, Albrecht E, Guerrini R, Bienert M.
    J Pharmacol Exp Ther; 2000 Aug 16; 294(2):428-33. PubMed ID: 10900215
    [Abstract] [Full Text] [Related]

  • 32. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
    Chen X, McClatchy DB, Geller EB, Liu-Chen L, Tallarida RJ, Adler MW.
    Brain Res; 2001 Jun 22; 904(2):252-8. PubMed ID: 11406123
    [Abstract] [Full Text] [Related]

  • 33. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G.
    Peptides; 2009 Feb 22; 30(2):248-55. PubMed ID: 18992780
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
    Asth L, Ruzza C, Malfacini D, Medeiros I, Guerrini R, Zaveri NT, Gavioli EC, Calo' G.
    Neuropharmacology; 2016 Jun 22; 105():434-442. PubMed ID: 26867504
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.
    Rizzi A, Rizzi D, Marzola G, Regoli D, Larsen BD, Petersen JS, Calo' G.
    Br J Pharmacol; 2002 Oct 22; 137(3):369-74. PubMed ID: 12237257
    [Abstract] [Full Text] [Related]

  • 38. Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.
    Krowicki ZK, Kapusta DR, Hornby PJ.
    Br J Pharmacol; 2000 Aug 22; 130(7):1639-45. PubMed ID: 10928969
    [Abstract] [Full Text] [Related]

  • 39. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP.
    Curr Drug Targets; 2007 Jan 22; 8(1):117-35. PubMed ID: 17266536
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.